SpectronRx is a Contract Development and Manufacturing Organisation (CDMO) that specialises in the pharmaceutical industry. Distinguished by its FDA and EMA inspections, the company is equipped to handle multiple therapeutic and diagnostic isotope pharmaceutical grades, including Pb-212, Lu-177, Ac-225, and I-131, for a variety of clinical applications. With a strong commitment to quality, SpectronRx operates under a comprehensive quality programme that has gained approval for drugs such as FDG, NaF, and Ammonia. The company’s offerings also encompass labelling and contract manufacturing services tailored to various isotopes.

Services include:
– Containment
– Protein and Peptide
– Regulatory Services
– Labelling and Contract Manufacturing for isotopes like Lu-177, Ac-225, I-131, I-124, I-111, Zr-89, Copper-64, and Fluorine-18

As a prominent player in the pharmaceutical landscape, SpectronRx continues to deliver high-quality services essential for the development and manufacture of radiopharmaceuticals. For more information, please visit spectronrx.com.